61 related articles for article (PubMed ID: 7629886)
1. Risk of cancer in relatives of prostate cancer probands.
Isaacs SD; Kiemeney LA; Baffoe-Bonnie A; Beaty TH; Walsh PC
J Natl Cancer Inst; 1995 Jul; 87(13):991-6. PubMed ID: 7629886
[TBL] [Abstract][Full Text] [Related]
2. Prostate cancer risk prediction based on complete prostate cancer family history.
Albright F; Stephenson RA; Agarwal N; Teerlink CC; Lowrance WT; Farnham JM; Albright LA
Prostate; 2015 Mar; 75(4):390-8. PubMed ID: 25408531
[TBL] [Abstract][Full Text] [Related]
3. Harnessing Population Pedigree Data and Machine Learning Methods to Identify Patterns of Familial Bladder Cancer Risk.
Hanson HA; Leiser CL; O'Neil B; Martin C; Gupta S; Smith KR; Dechet C; Lowrance WT; Madsen MJ; Camp NJ
Cancer Epidemiol Biomarkers Prev; 2020 May; 29(5):918-926. PubMed ID: 32098890
[TBL] [Abstract][Full Text] [Related]
4. Triple Primary Cancers: An Analysis of Genetic and Environmental Factors.
Borja NA; Silva-Smith R; Calfa C; Sussman DA; Tekin M
Cancer Prev Res (Phila); 2024 May; 17(5):209-215. PubMed ID: 38361103
[TBL] [Abstract][Full Text] [Related]
5. Population prevalence of hereditary breast cancer phenotypes and implementation of a genetic cancer risk assessment program in southern Brazil.
Palmero EI; Caleffi M; Schüler-Faccini L; Roth FL; Kalakun L; Netto CB; Skonieski G; Giacomazzi J; Weber B; Giugliani R; Camey SA; Ashton-Prolla P
Genet Mol Biol; 2009 Jul; 32(3):447-55. PubMed ID: 21637504
[TBL] [Abstract][Full Text] [Related]
6. Familial multiple myeloma: report on two families and discussion of screening options.
Gerkes EH; de Jong MM; Sijmons RH; Vellenga E
Hered Cancer Clin Pract; 2007 Jun; 5(2):72-8. PubMed ID: 19725987
[TBL] [Abstract][Full Text] [Related]
7. Improving Care for Marginalized Populations at Risk for Hereditary Cancer Syndromes: Innovations that Expanded Reach in the CHARM Study.
Gilmore MJ; Knerr S; Kraft SA; Bulkley JE; Biesecker BB; Feigelson HS; Hunter JE; Jenkins CL; Kauffman TL; Lee SS; Liles EG; Mittendorf KF; Muessig KR; Porter KM; Rolf BA; Rope AF; Zepp JM; Anderson KP; Devine B; Joseph G; Leo MC; Goddard K; Wilfond BS
Public Health Genomics; 2024; 27(1):16-22. PubMed ID: 38142673
[No Abstract] [Full Text] [Related]
8. Hereditary and familial prostate cancer: biologic aggressiveness and recurrence.
Potter SR; Partin AW
Rev Urol; 2000; 2(1):35-6. PubMed ID: 16985733
[No Abstract] [Full Text] [Related]
9. First-degree family history of breast cancer is associated with prostate cancer risk: a systematic review and meta-analysis.
Ren ZJ; Cao DH; Zhang Q; Ren PW; Liu LR; Wei Q; Wei WR; Dong Q
BMC Cancer; 2019 Sep; 19(1):871. PubMed ID: 31477094
[TBL] [Abstract][Full Text] [Related]
10. Familial clustering of breast and prostate cancer and risk of postmenopausal breast cancer in the Women's Health Initiative Study.
Beebe-Dimmer JL; Yee C; Cote ML; Petrucelli N; Palmer N; Bock C; Lane D; Agalliu I; Stefanick ML; Simon MS
Cancer; 2015 Apr; 121(8):1265-72. PubMed ID: 25754547
[TBL] [Abstract][Full Text] [Related]
11. A case of synchronous double malignancy: Invasive bladder cancer and Leiomyosarcoma of extremity and review of literature.
Viveka BK; Amirtham U; Kumar VM; Babu GK
South Asian J Cancer; 2013 Jul; 2(3):152. PubMed ID: 24455603
[No Abstract] [Full Text] [Related]
12. Common genetic variants associated with disease from genome-wide association studies are mutually exclusive in prostate cancer and rheumatoid arthritis.
Orozco G; Goh CL; Al Olama AA; Benlloch-Garcia S; Govindasami K; Guy M; Muir KR; Giles GG; Severi G; Neal DE; Hamdy FC; Donovan JL; Kote-Jarai Z; Easton DF; Eyre S; Eeles RA
BJU Int; 2013 Jun; 111(7):1148-55. PubMed ID: 22985493
[TBL] [Abstract][Full Text] [Related]
13. Prostate cancer risk in men with prostate and breast cancer family history: results from the REDUCE study (R1).
Thomas JA; Gerber L; Moreira DM; Hamilton RJ; Bañez LL; Castro-Santamaria R; Andriole GL; Isaacs WB; Xu J; Freedland SJ
J Intern Med; 2012 Jul; 272(1):85-92. PubMed ID: 22211699
[TBL] [Abstract][Full Text] [Related]
14. The genetics of cancer risk.
Pomerantz MM; Freedman ML
Cancer J; 2011; 17(6):416-22. PubMed ID: 22157285
[TBL] [Abstract][Full Text] [Related]
15. An epidemiological reappraisal of the familial aggregation of prostate cancer: a meta-analysis.
Kiciński M; Vangronsveld J; Nawrot TS
PLoS One; 2011; 6(10):e27130. PubMed ID: 22073129
[TBL] [Abstract][Full Text] [Related]
16. Using family history information to promote healthy lifestyles and prevent diseases; a discussion of the evidence.
Claassen L; Henneman L; Janssens AC; Wijdenes-Pijl M; Qureshi N; Walter FM; Yoon PW; Timmermans DR
BMC Public Health; 2010 May; 10():248. PubMed ID: 20465810
[TBL] [Abstract][Full Text] [Related]
17. The clinical genetics of prostate cancer.
Kommu S; Edwards S; Eeles R
Hered Cancer Clin Pract; 2004 Jul; 2(3):111-21. PubMed ID: 20233465
[TBL] [Abstract][Full Text] [Related]
18. Prostate cancer old problems and new approaches : Part I. epidemiology, incidence and genetic alterations.
Honn KV; Aref A; Chen YQ; Cher ML; Crissman JD; Forman JD; Gao X; Grignon D; Hussain M; Porter AT; Pontes JE; Powell I; Redman B; Sakr W; Severson R; Tang DG; Wood DP
Pathol Oncol Res; 1996 Mar; 2(1-2):98-109. PubMed ID: 18443924
[TBL] [Abstract][Full Text] [Related]
19. Inherited predisposition to prostate cancer.
Verhage BA; Kiemeney LA
Eur J Epidemiol; 2003; 18(11):1027-36. PubMed ID: 14620936
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
